Lupus Awareness Month
Creating a Culture of Holistic Care in Lupus
Lupus is a chronic disease that can cause organ damage and hospitalization, resulting in high costs. GSK aims to improve care by considering social determinants of health.
Investors
We announced our quarter 1 2024 results on Wednesday, May 1st.
Press releases
- US FDA accepts for priority review GSK’s application for an expanded indication of Jemperli (dostarlimab-gxly) plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
- New long-term data show SHINGRIX continues to provide high protection against shingles in adults aged 50 and over for more than a decade
- GSK’s 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA
Choose your path
By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health.
GSK Global links
Visit our Global site for additional features